| Announce Date | 11/13/2025 |
| EPS Normalized Actual | $0.08174 (Beat by $0.04174) |
| EPS GAAP Actual | $0.08174 (Beat by $0.04174) |
| Revenue Actual | $0.162482B |
| Revenue Surprise | Beat by $162.482M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.145 |
| EPS GAAP Estimate | $0.145 |
| Revenue Estimate | $0.1773375B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0 | INF | 0 | 0 | 0 |
| Dec 2025 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.08 | 0 | 0.162482B | 16.75% | 14.11M |
| FQ2 2025 (Jun 2025) | 0.16 | 0.16 | 0.172108B | 5.25% | 4.19M |
| FQ1 2025 (Mar 2025) | 0.2 | 0.08333 | 0.164226B | 100% | 12.55M |
| FQ4 2024 (Dec 2024) | -0.32 | -0.345 | 0.136827B | 100% | 5.33M |
| FQ3 2024 (Sep 2024) | 0.22 | 0.213333 | 0.135271B | 100% | 0.49M |
| FQ2 2024 (Jun 2024) | 0 | -0.015 | 0.163066B | 100% | 14.32M |
| FQ4 2021 (Nov 2021) | -0.0003 | -0.0003 | 0B | NAN% | 0M |
| FQ1 2022 (Mar 2022) | -0.0111 | -0.0111 | 0B | NAN% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.145
Consensus Revenue Estimates
0.1773375B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.03 | -- | 0.02944454 | 0.03057 | 1 |
| FQ3 2026 (Sep 2026) | 0.11 | 27.27 | 0.10915 | 0.11102 | 1 |
| FQ2 2026 (Jun 2026) | 0.16 | 0 | 0.15876 | 0.16149 | 1 |
| FQ1 2026 (Mar 2026) | 0.145 | -37.93 | 0.14232 | 0.14775 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.16B | -- | 0.16B | 0.16B | 2 |
| FQ3 2026 (Sep 2026) | 0.17B | 3.34 | 0.17B | 0.17B | 2 |
| FQ2 2026 (Jun 2026) | 0.18B | 4.22 | 0.18B | 0.18B | 2 |
| FQ1 2026 (Mar 2026) | 0.18B | 7.39 | 0.17B | 0.18B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
0
Revenue # of in-lines
2
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.08 | 0.08 | 0 | 0% |
| FQ2 2025 (Jun 2025) | 0 | 0.16 | 0.16 | 100% |
| FQ1 2025 (Mar 2025) | 0.11667 | 0.2 | 0.08333 | 41.67% |
| FQ4 2024 (Dec 2024) | 0.025 | -0.32 | -0.345 | 107.81% |
| FQ3 2024 (Sep 2024) | 0.006667 | 0.22 | 0.213333 | 96.97% |
| FQ2 2024 (Jun 2024) | 0.015 | 0 | -0.015 | -INF% |
| FQ4 2021 (Nov 2021) | -0.0003 | -0.0003 | 100% | |
| FQ1 2022 (Mar 2022) | -0.0111 | -0.0111 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.15B | $0.16B | $14.11M | 8.68% |
| FQ2 2025 (Jun 2025) | $0.17B | $0.17B | $4.19M | 2.44% |
| FQ1 2025 (Mar 2025) | $0.15B | $0.16B | $12.55M | 7.64% |
| FQ4 2024 (Dec 2024) | $0.13B | $0.14B | $5.33M | 3.9% |
| FQ3 2024 (Sep 2024) | $0.13B | $0.14B | $0.49M | 0.37% |
| FQ2 2024 (Jun 2024) | $0.15B | $0.16B | $14.32M | 8.78% |
| FQ4 2021 (Nov 2021) | $0B | $0B | $0M | NAN% |
| FQ1 2022 (Mar 2022) | $0B | $0B | $0M | NAN% |